© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Patient Care Editorial Staff
Articles
FMX 2025: American Academy of Family Physicians Main Stage Speakers
October 01, 2025
This year, the FMX Main Stage presenters will be led by Vivek H Murthy, the 21st US Surgeon General. Learn more about him and the 2 other inspiring guests.
Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care
September 24, 2025
Patient Care tapped the rich trove of research and expert perspective from the 2025 Revolutionizing Atopic Dermatitis meeting to create a snapshot of the AD care of the future.
Oral PCSK9 Inhibitor Enlicitide Meets All End Points in Phase 3 Hypercholesterolemia Trial
September 02, 2025
At week 24, patients receiving once-daily enlicitide demonstrated statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol compared with placebo.
FDA Approves Subcutaneous Leqembi Autoinjector for Maintenance Therapy in Early Alzheimer Disease
September 01, 2025
The FDA has cleared Eisai and Biogen’s Leqembi Iqlik, the first at-home subcutaneous autoinjector for maintenance therapy in patients with early Alzheimer disease.
FDA Approves Semaglutide 2.4 mg for Treatment of MASH Without Cirrhosis
August 16, 2025
The accelerated approval for semaglutide 2.4 mg for the treatment of noncirrhotic MASH was based on part 1 of the phase 3 ESSENCE trial, which met its primary endpoints.
New Fibromyalgia Treatment: FDA Approves Once-Daily Nonopioid Analgesic TNX-102 SL
August 15, 2025
The US FDA approved Tonmya, a groundbreaking treatment for fibromyalgia, offering hope to millions experiencing chronic pain and sleep issues.
5 Challenges Physicians Face When Screening for Cognitive Decline
June 19, 2025
Primary care clinicians are generally the first clinical contact for older adults with early signs of dementia. Our survey uncovered 5 primary challenges to being in that role.
Physician Survey Results: Primary Care Knowledge of Screening for Cognitive Decline
June 17, 2025
New survey finds that most PCPs screen for mild cognitive impairment, but time is an issue, guidelines are few, and low levels of confidence persist.
FDA Clears First Plasma-Based Assay to Aid Alzheimer Disease Diagnosis
May 17, 2025
The diagnostic is designed to help clinicians determine the likelihood of cerebral β-amyloid plaque deposition, one of the neuropathologic hallmarks of AD.